← Back to Search

Local Anesthetic

ESPB Solutions for Breast Cancer

Phase 2

Waitlist Available

Research Sponsored by Tufts Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 72 hours

Awards & highlights

Study Summary

This trial will compare pain scores of two different methods of pain management for subjects undergoing bilateral surgical intervention for breast cancer.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 72 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~72 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 72 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Pain Score at 48 hours

Secondary outcome measures

Pain Scores at 6, 12, 18, 24, 30, 38, 42, and 72 hours

Trial Design

2Treatment groups

Active Control

Group I: ControlActive Control1 Intervention

Control arm will receive standard of care solution for the ESPB block

Group II: Liposomal BupivicaineActive Control1 Intervention

Liposomal Bupivicaine arm will receive Liposomal Bupivicaine for the ESPB block

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Tufts Medical CenterLead Sponsor

252 Previous Clinical Trials

252,923 Total Patients Enrolled

4 Trials studying Breast Cancer

1,783 Patients Enrolled for Breast Cancer

Media Library

Liposomal bupivacaine (Local Anesthetic) Clinical Trial Eligibility Overview. Trial Name: NCT04603911 — Phase 2

Breast Cancer Research Study Groups: Control, Liposomal Bupivicaine

Breast Cancer Clinical Trial 2023: Liposomal bupivacaine Highlights & Side Effects. Trial Name: NCT04603911 — Phase 2

Liposomal bupivacaine (Local Anesthetic) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04603911 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Would someone who is 34 years old still qualify to participate in this research study?

"This particular clinical trial is only open to patients aged 18-75. In comparison, there are 155 trials for patients who are below the age of 18 and 2008 for those over 65 years old."

Answered by AI

For which patient population is this research project recruiting?

"This study is only open to individuals that have a diagnosis of breast cancer and are between the ages of 18-75. The researchers need 75 total participants."

Answered by AI

What afflictions does Control typically address?

"Control has been shown to be an effective treatment for ophthalmia, sympathetic, branch retinal vein occlusion, and laryngotracheobronchitis."

Answered by AI

How many people are included in the data set of this research?

"That is correct. The listing on clinicaltrials.gov says that the trial, which was first announced on December 4th 2020, is still looking for patients. They need 75 people to participate and right now they are only recruiting at 1 location."

Answered by AI

Are we still able to sign up for this experiment?

"Yes, this is accurate. The trial in question was posted on December 4th 2020 and updated most recently on June 1st 2022. According to the website, they are still recruiting patients for the study."

Answered by AI